A less-than-encouraging clinical trial for an investigative medicine was the news driving down Incyte (NASDAQ: INCY) stock over the past few days. The gloom this produced was pushing the biotech's share...
1 Healthcare Stock on Our Watchlist and 2 to Brush Off
Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -1.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.62%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.66%. March E-mini...
Shares of Incyte INCY were down 8.62% on Monday after the announcement of data from two late-stage studies on an oral small-molecule JAK1 inhibitor, povorcitinib, for the treatment of hidradenitis suppurativa...
The S&P 500 Index ($SPX ) (SPY ) today is down -1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.89%. March E-mini S&P futures...
The S&P 500 Index ($SPX ) (SPY ) today is down -1.01%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.50%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.73%. March E-mini S&P futures...
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.85%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.55%. March E-mini S&P...